The Weizmann Institute of Science in Rehovot, Israel, has devised a
noninvasive technique for diagnosing whether a tumour is benign or malignant. A
contrast-enhancing dye is injected into the patient’s bloodstream and magnetic
resonance imaging is used to watch it pass through the tumour. The spaces
between cells and the presence or absence of blood vessels determine the rate at
which the dye passes through. In benign tumours the dye accumulates and washes
out slowly, but in malignant cancers it passes straight through.
More from New ÒÁÈ˾þÃ
Explore the latest news, articles and features
Life
Himalayan wolf-dog hybrids emerge as a threat to wolves and people
News
Environment
First test of CO2 removal with green sand finds no harm to marine life
News
Space
SpaceX is about to launch tallest and most powerful rocket in history
News
Environment
Cleaning up air pollution could weaken vital AMOC ocean current
News
Popular articles
Trending New ÒÁÈ˾þà articles
1
Why autism pioneer Uta Frith wants to dismantle the spectrum
2
Where did the laws of physics come from? I think I've found the answer
3
Neanderthals treated a dental cavity by drilling into the tooth
4
SpaceX is about to launch tallest and most powerful rocket in history
5
First test of CO2 removal with green sand finds no harm to marine life
6
Himalayan wolf-dog hybrids emerge as a threat to wolves and people
7
A new tectonic plate boundary could be forming in southern Africa
8
CAR T-cell therapy bolstered by stiffening up cancer cells first
9
Human brain cells on a chip learned to play Doom in a week
10
100-year-old assumption about the universe may soon be overturned
